N-Drugs, Return to Work, OxyContin Saga and More

by myMatrixx

In the Fall Issue of myMatrixx’s newsletter, The Monitor, our clinical team reviews the Texas Closed Formulary and explains some of the confusion around N-drugs. We also take a look at the continuing Oxycontin saga, share best practices from industry leaders on Return to Work programs, and explain recent legislation adopted in California and Texas. Read the issue here.